Aptose Biosciences Financial Overview
Aptose Biosciences's market cap is currently C$5.31M. The company's EPS TTM is C$-2.7726661991999997; its P/E ratio is -0.18; Aptose Biosciences is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
